Cardinal Health, Inc.

New York Stock Exchange
Back to all articles
Slightly Bearish -20

Cardinal Health (CAH) Stock Looks Pricey Following Its Home Care Deal Push

AI-generated analysis

📈 Cardinal Health has delivered a very strong 334.8% return over the past five years and 49.3% in the last year.

💰 The stock currently trades at approximately 35.0x earnings, compared to an industry average of roughly 26.9x and a peer group average of about 28.1x.

📉 The model's fair P/E ratio sits near 29.2x, suggesting the current price includes a premium for future growth expectations.

🏥 Cardinal Health is pursuing growth through planned acquisitions of Strive Medical and AdaptHealth to expand its home-based care portfolio.

⚖️ The stock only passes two of six valuation checks, indicating it does not screen as a clear bargain on broader value tests.

🤔 Investors face the challenge of determining if current share price strength already prices in the expected benefits of the expansion.

🛠️ Success depends on execution and integration outcomes for the home care deals to justify today's premium valuation.

Bullish Signals
  • Cardinal Health has delivered exceptional long-term performance with a 334.8% return over five years and a 49.3% gain in the last year.
  • The company is executing a strategic expansion into home-based care through planned acquisitions of Strive Medical and AdaptHealth.
Risk Factors
  • Cardinal Health trades at a P/E multiple of approximately 35.0x, which is significantly higher than the industry average of roughly 26.9x and peer group average of about 28.1x.
  • The current valuation suggests investors are paying a premium that may not be fully supported by current earnings without successful integration of new deals.
Full Analysis
Simply Wall St analysis indicates that Cardinal Health (CAH) stock appears overvalued following a strong 334.8% return over the past five years and a 49.3% gain in the last year. The company currently trades at approximately 35.0x earnings, which is significantly higher than the broader healthcare industry average of roughly 26.9x and its peer group average of about 28.1x. The article argues that the current valuation premium likely prices in optimism regarding Cardinal Health's strategic push into home-based care through planned acquisitions of Strive Medical and AdaptHealth. While management expects these deals to support earnings growth, the stock only passes two of six valuation checks, suggesting it is not a clear bargain based on fundamental metrics. Investors are now relying more on strong execution than valuation support for future upside. The key question remains whether Cardinal Health can successfully deliver on its home care expansion and integration outcomes to justify the current premium before market sentiment or multiples cool down.